Molecular therapy for Miscarriage: Lin-28, the RNA binding protein, may inhibit early pregnancy loss and promote fetal growth via down regulation of its target gene, 23/March/2015, 22.26

MiRNA-based therapy for Fibrosis: NR2F2 suppresses TGFβ-dependent extracellular matrix accumulation and fibrosis via up regulation of its target gene, 23/March/2015, 22.09
March 23, 2015
Natural product-based therapy for pulmonary arterial hypertension: Berberine inhibits the development of pulmonary arterial hypertension via down regulation of its target gene, 24/March/2014, 07.17 am
March 24, 2015
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Web: http://genomediscovery.org

Significance:  This study suggests, for the first time, that Lin-28, by decreasing the expression of its target gene, it may inhibit early pregnancy loss, while promoting fetal growth. Thus, pharmacological formulations encompassing “Lin-28 activators” may be used to protect pregnant women from miscarriage, while promoting fetal growth. 

CitationBoominathan, Molecular therapy for Miscarriage: Lin-28, the RNA binding protein,  may inhibit early pregnancy loss and promote fetal growth via down regulation of its target gene, 23/March/2015,  22.26, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Undisclosed information: How Lin-28 inhibits early pregnancy loss and promotes fetal growth

* Research cooperation

Comments are closed.